SimianX AI LogoSimianX AI

Asset profile

hydrocortisone · Eton Pharmaceuticals (ETON)

Indication
adrenocortical insufficiency
Also known as
KHINDIVI
CompanyETONEton Pharmaceuticals

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKI…

Start live analysis of ETONRun 8-agent AI analysis

On the calendar

Nothing scheduled in this window.

Timeline

Newest first.

Oct 15, 2026
06:58 PM
ETONEton Pharmaceuticals

hydrocortisone · FDA label updated (effective 20251215)

FDA label updateFDA label (openFDA)
Jul 29, 2026
10:50 AM
ETONEton Pharmaceuticals

Eton submits PAS to expand KHINDIVI label to younger pediatric patients

Application submittedCompany press releaseOpen record

More from Eton Pharmaceuticals

Other drugs and candidates from the same company tracked in this sector.

desmopressin acetatecentral diabetes insipidus (arginine vasopressin deficiency, AVP-D)ET-600miltefosineVisceral, cutaneous, and mucosal leishmaniasistimolol topical gelproliferating superficial infantile hemangiomas
hydrocortisone · Eton Pharmaceuticals (ETON) — FDA Timeline & Readiness Checklist | SimianX AI